Insilico to contribute to Oxford CDT research and educational program in AI

(InSilico Medicine, Inc.) Insilico Medicine, a Rockville-based company developing the end-to-end drug discovery pipeline utilizing the next generation artificial intelligence, announces its partnership with a new Centre for Doctoral Training (CDT) at the University of Oxford, supported by EPSRC (The Engineering and Physical Sciences Research Council).
Source: EurekAlert! - Biology - Category: Biology Source Type: news